-transparent.png){kind=logo}
Glucagon secretion plays an essential role in the regulation of hepatic glucose production, and elevated fasting and postprandial plasma glucagon concentrations in patients with type 2 diabetes (T2DM) contribute to their hyperglycaemia. The reason for the hyperglucagonaemia is unclear, but recent studies have shown lack of suppression after oral but preserved suppression after isoglycaemic intravenous glucose, pointing to factors from the gut. Gastrointestinal hormones that are secreted in response to oral glucose include glucagon-like peptide-1 (GLP-1) that strongly inhibits glucagon secretion, and GLP-2 and GIP, both of which stimulate secretion. When the three hormones are given together on top of isoglycaemic intravenous glucose, glucagon suppression is delayed in a manner similar to that observed after oral glucose. Studies with the GLP-1 receptor antagonist, exendin 9-39, suggest that endogenous GLP-1 plays an important role in regulation of glucagon secretion during fasting as well as postprandially. The mechanisms whereby GLP-1 regulates glucagon secretion are debated, but studies in isolated perfused rat pancreas point to an important role for a paracrine regulation by somatostatin from neighbouring D cells. Clinical studies of the antidiabetic effect of GLP-1 in T2DM suggest that the inhibition of glucagon secretion is as important as the stimulation of insulin secretion.
J J Holst, and
M Christensen, and
A Lund, and
J de Heer, and
B Svendsen, and
U Kielgast, and
F K Knop
October 2002,
Nihon rinsho. Japanese journal of clinical medicine,
J J Holst, and
M Christensen, and
A Lund, and
J de Heer, and
B Svendsen, and
U Kielgast, and
F K Knop
October 1976,
Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
J J Holst, and
M Christensen, and
A Lund, and
J de Heer, and
B Svendsen, and
U Kielgast, and
F K Knop
January 1983,
Advances in metabolic disorders,
J J Holst, and
M Christensen, and
A Lund, and
J de Heer, and
B Svendsen, and
U Kielgast, and
F K Knop
January 2014,
Diabetes research and clinical practice,
J J Holst, and
M Christensen, and
A Lund, and
J de Heer, and
B Svendsen, and
U Kielgast, and
F K Knop
September 2023,
The Journal of endocrinology,
J J Holst, and
M Christensen, and
A Lund, and
J de Heer, and
B Svendsen, and
U Kielgast, and
F K Knop
January 2004,
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
J J Holst, and
M Christensen, and
A Lund, and
J de Heer, and
B Svendsen, and
U Kielgast, and
F K Knop
February 2022,
Nature reviews. Endocrinology,
J J Holst, and
M Christensen, and
A Lund, and
J de Heer, and
B Svendsen, and
U Kielgast, and
F K Knop
January 1984,
Acta diabetologica latina,
J J Holst, and
M Christensen, and
A Lund, and
J de Heer, and
B Svendsen, and
U Kielgast, and
F K Knop
October 2011,
Diabetes, obesity & metabolism,
J J Holst, and
M Christensen, and
A Lund, and
J de Heer, and
B Svendsen, and
U Kielgast, and
F K Knop
January 2010,
Vitamins and hormones,
